Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/13773

Pentachlorophenol, Dowicide EC-7: Target Organs and Levels of Evidence for TR-349

Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures (CASRN 87-86-5) in B6C3F1 Mice (Feed Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Pentachlorophenol, Dowicide EC-7
87-86-5
04/18/1988 Dosed-Feed
M: 0, 100, 200, 600 PPM
Battelle Columbus Laboratory

Levels of Evidence

Male Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 5/35 13/48 17/48 32/49 OR CARCINOMA 1/35 7/48 7/48 9/49 COMBINED 6/35 19/48 21/48 34/49
  • Adrenal Gland Medulla: PHEOCHROMOCYTOMA 0/34 4/48 21/48 44/49 OR MALIGNANT PHEOCHROMOCYTOMA 1/34 0/48 0/48 3/49 COMBINED 1/34 4/48 21/48 45/49
Non-Neoplastic Lesions
  • LIVER: CLEAR CELL FOCUS 0/35 19/48 21/48 19/49; INFLAMMATION, CHRONIC, ACTIVE 0/35 36/48 44/48 43/49; PIGMENTATION 0/35 40/48 37/48 45/49; BILE DUCT, HYPERPLASIA 1/35 3/48 5/48 32/49; HEPATOCYTE, CYTOMEGALY 0/35 48/48 48/48 47/49; HEPATOCYTE, NECROSIS, ACUTE 1/35 47/48 47/48 46/49
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Vascular System (Liver): HEMANGIOSARCOMA 0/34 1/50 1/49 8/48
  • Liver: ADENOMA 1/34 3/50 6/49 30/48 OR CARCINOMA 0/34 1/50 0/49 1/48 COMBINED 1/34 4/50 6/49 31/48
  • Adrenal Gland Medulla: PHEOCHROMOCYTOMA 0/35 2/49 2/46 38/49
  • Vascular System (Spleen): HEMANGIOSARCOMA 0/34 0/50 2/50 2/47
Non-Neoplastic Lesions
  • LIVER: CLEAR CELL FOCUS 1/34 2/50 13/49 26/48; INFLAMMATION, CHRONIC, ACTIVE 0/34 4/50 30/49 47/48; PIGMENTATION 0/34 4/50 32/49 48/48; BILE DUCT, HYPERPLASIA 0/34 0/50 1/49 40/48; HEPATOCYTE, CYTOMEGALY 0/34 38/50 49/49 47/48; HEPATOCYTE, NECROSIS, ACUTE 2/34 25/50 49/49 48/48


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Pentachlorophenol, DP-2
87-86-5
Dosed-Feed Battelle Columbus Laboratory

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Pentachlorophenol, purified
87-86-5
Dosed-Feed Battelle Columbus Laboratory

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Pentachlorophenol, technical
87-86-5
04/18/1988 Dosed-Feed
M: 0, 100, 200 PPM
Battelle Columbus Laboratory

Levels of Evidence

Male Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 5/32 20/47 33/48 OR CARCINOMA 2/32 10/47 12/48 COMBINED 7/32 26/47 37/48
  • Adrenal Gland Medulla: PHEOCHROMOCYTOMA 0/31 10/45 23/45
Female Mice: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Vascular System (Liver): HEMANGIOSARCOMA 0/33 2/49 4/50
  • Liver: ADENOMA 3/33 8/49 8/50 OR CARCINOMA 0/33 1/49 1/50 COMBINED 3/33 9/49 9/50
  • Vascular System (Spleen): HEMANGIOSARCOMA 0/33 1/50 3/47